BMP5/7 protect dopaminergic neurons in an alpha-synuclein mouse model of Parkinson's disease

被引：0

作者：

Vitic, Zagorka ^{[1
]}

Safory, Hazem ^{[2
,3
]}

Jovanovic, Vukasin M. ^{[4
]}

Sarusi, Yael ^{[1
]}

Stavsky, Alexandra ^{[1
]}

Kahn, Joy ^{[1
]}

Kuzmina, Alona ^{[5
]}

Toker, Lilah ^{[6
,7
]}

Gitler, Daniel ^{[1
]}

Taube, Ran ^{[5
]}

Friedel, Roland H. ^{[8
]}

Engelender, Simone ^{[2
,3
]}

Brodski, Claude ^{[1
]}

机构：

[1] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Zlotowski Ctr Neurosci, Fac Hlth Sci, IL-84105 Beer Sheva, Israel

[2] Technion Israel Inst Technol, B Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel

[3] Technion Israel Inst Technol, Inst Med Res, IL-31096 Haifa, Israel

[4] Natl Inst Hlth NIH, Natl Ctr Adv Translat Sci NCATS, Stem Cell Translat Lab SCTL, Rockville, MD 20850 USA

[5] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, Fac Hlth Sci, IL-84105 Beer Sheva, Israel

[6] Haukeland Hosp, Dept Neurol, NeuroSysMed Ctr Excellence Clin Res Neurol Dis, N-5021 Bergen, Norway

[7] Univ Bergen, Dept Clin Med, N-5007 Bergen, Norway

[8] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Neurosci & Neurosurg, New York, NY 10029 USA

来源：

BRAIN | 2021年 / 144卷

基金：

以色列科学基金会;

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页数：6

共 50 条

[41] Parkinson's Disease, Cortical Dysfunction, and Alpha-Synuclein
Caviness, John N.
Lue, Lih-Fen
Beach, Thomas G.
Hentz, Joseph G.
Adler, Charles H.
Sue, Lucia
Sadeghi, Ramin
Driver-Dunckley, Erika
Evidente, Virgilio G.
Sabbagh, Marwan N.
Shill, Holly A.
Walker, Douglas G.
MOVEMENT DISORDERS, 2011, 26 (08) : 1436 - 1442
[42] Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
Fields, Carroll Rutherford
Bengoa-Vergniory, Nora
Wade-Martins, Richard
FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
[43] Modeling Parkinson's Disease With the Alpha-Synuclein Protein
Gomez-Benito, Monica
Granado, Noelia
Garcia-Sanz, Patricia
Michel, Anne
Dumoulin, Mireille
Moratalla, Rosario
FRONTIERS IN PHARMACOLOGY, 2020, 11
[44] Alpha-synuclein and the prion hypothesis in Parkinson's disease
Melki, R.
REVUE NEUROLOGIQUE, 2018, 174 (09) : 644 - 652
[45] Lipids and alpha-synuclein aggregation in Parkinson's disease
Broersen, K.
Davletov, B.
MOVEMENT DISORDERS, 2007, 22 (12) : VI - VI
[46] Familial Parkinson's disease - The awakening of alpha-synuclein
Goedert, M
NATURE, 1997, 388 (6639) : 232 - 233
[47] Sumoylation of alpha-synuclein in the pathogenesis of parkinson's disease
Engelender, S.
JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 48 - 48
[48] Autoantibodies to alpha-synuclein in inherited Parkinson's disease
Papachroni, Katerina K.
Ninkina, Natalia
Papapanagiotou, Angeliki
Hadjigeorgiou, Georgios M.
Xiromerisiou, Georgia
Papadimitriou, Alexandros
Kalofoutis, Anastasios
Buchman, Vladimir L.
JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 749 - 756
[49] A Characterization of Misfolded Alpha-Synuclein in Parkinson's Disease
Shannon, Daniel
Bugada, John-Paul
Collins, Ethan
Fischer, Ellie
Hellard, Delaney
Hoffman, Trevor
Kellogg, Nick
Peters, Kyle
Poetker, Garret
Young, Logan
Diao, JiaJie
FASEB JOURNAL, 2020, 34
[50] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
Dolgacheva L.P.
Fedotova E.I.
Abramov A.Y.
Berezhnov A.V.
Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 2018, 12 (1) : 10 - 19

← 1 2 3 4 5 →